June K. Robinson, MD
Jeffrey P. Callen, MD
JAMA Dermatology (formerly the Archives of Dermatology) has been in continuous publication since October 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology; in 1955, it continued publication as Archives of Dermatology. It is an international peer-reviewed journal published 12 times a year; the online version is published on the third Wednesday of the month. A Middle Eastern and an Indian edition are published bimonthly. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery. Annually, the journal publishes theme issues on topics selected by the editors of The JAMA Network as being of importance to the health of the nation, such as comparative effectiveness research (2012), infectious disease and immunology (2011), and cancer of the skin (2010). The acceptance rate is 21%, with an average of 155 days from acceptance to publication, 69 days for articles published online first. Its 2013 impact factor is 4.3 (the impact factor is a measure of citation rate per article, and is calculated by dividing 1 year's worth of citations to a journal's articles published in the previous 2 years by the number of major articles [eg, research papers, reviews] published by that journal in those 2 years). The editor is June K. Robinson, MD, Northwestern University, Feinberg School of Medicine, Chicago, Illinois and the associate editor is Jeffrey P. Callen, MD, University of Louisville School of Medicine, Louisville, Kentucky.
Mission Statement: JAMA Dermatology publishes information concerning the skin, its diseases, and their treatment. Its mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders. This journal has a particular interest in publishing clinical and laboratory studies that reveal new information pertinent to the interests and needs of the medical dermatologist, dermatologic surgeon, and all those concerned with state-of-the-art care of cutaneous disease. We believe that knowledge derived from well-designed clinical trials and studies of cost-effectiveness are especially important for improving the practice of dermatology. Studies that increase the understanding of the outcome of treatment or the means by which the burden of dermatologic disease can be measured and reduced to promote the health of patients with skin disease will receive special priority. The journal regularly publishes reports on clinical investigations, editorials, and reviews. It also features reports and discussions on clinicopathologic correlations; clinical disorders of unique didactic value; pharmacologic, medical and surgical therapeutics; and ethical, moral, socioeconomic, and political issues.
Access for Developing Countries: The online version of JAMA Dermatology is made freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Print: ISSN 2168-6068
Online: ISSN 2168-6084